T
Travere Therapeutics (TVTX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Travere Therapeutics (TVTX)
Travere Therapeutics Inc., formerly Retrophin Inc., is a biopharmaceutical company. The Company specializing in identifying, developing and delivering therapies to people living with rare disease. It's pipeline includes sparsentan (RE-021), a product... Read more
- USD5.40
- USD5.55
- USD5.21
- USD22.75
- -30.50%
- 145M
- 1.22M
- 1.37M
- 435M
- 5.12
- -74.50%
Stock News
4 hours ago
Many Canadians are delaying filing their taxes out of fear of owing money, survey says
Yahoo
4 hours ago
AI Boom’s Secret Winners? The Companies Expected to Power It
Yahoo
4 hours ago
Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Yahoo
4 hours ago
Should You Investigate Keysight Technologies, Inc. (NYSE:KEYS) At US$149?
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
